50.44
[]. A M Ehrly, et al. [Behavior of muscle tissue oxygen pressure in patients with severe intermittent claudication after oral administration of benzarone]. Med Welt. 98 Mar 4;4(9):27-4.
[2]. Emmanuel Tadjuidje, et al. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone. PLoS One. 202;7(4):e4806.
[]. H E Knehr, et al. [Effect of benzarone on the oxygen consumption and the mechanical activity of vascular smooth muscle]. Arzneimittelforschung. 98;(2):2-4.
[4]. Ho Jung Shin, et al. Interactions of urate transporter URAT in human kidney with uricosuric drugs. Nephrology (Carlton). 20 Feb;6(2):56-62.
[5]. I Pevny, et al. Benzaron allergy. Contact Dermatitis. 984 Aug;(2):22.
H02-H4
P264-P270-P27-P0